Form 4: DSS, Inc. Reports Share Disposals in Impact Biomedical Inc.

DSS, Inc. has reported the disposal of Impact Biomedical Inc. shares through a series of transactions, reducing its indirect holdings.

Summary

• DSS, Inc. has filed a Form 4 detailing changes in its beneficial ownership of Impact Biomedical Inc. stock.
• The transactions include the sale of 500 shares on November 12, 2024, at $2.757 per share, 200 shares on November 13, 2024, at $2.8 per share, and 5,000 shares on November 18, 2024, at $3.017 per share.
• These sales were executed by Sentinel Brokers Company, Inc., a majority-owned subsidiary of DSS, Inc.
• Following these transactions, DSS, Inc. indirectly holds 53,100 shares through Sentinel Brokers Company, Inc.
• DSS, Inc. also indirectly holds 1,345,482 shares through DSS BioHealth Security, Inc., 166,600 shares through DSS Securities, Inc., and 166,600 shares through DSS BlockChain Security, Inc., all of which are wholly-owned subsidiaries.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the sale of shares by a major shareholder, which could indicate a lack of confidence or a strategic shift.

Negatives

• DSS, Inc. has reduced its indirect holdings in Impact Biomedical Inc. through share disposals.

Risks

• Continued selling pressure from DSS, Inc. could negatively impact the share price of Impact Biomedical Inc.

Industry Context

This filing reflects standard reporting requirements for significant shareholders and provides insight into the trading activity of DSS, Inc. in relation to Impact Biomedical Inc.

Comparison to Industry Standards

• Form 4 filings are a standard practice for reporting changes in beneficial ownership by insiders and major shareholders in publicly traded companies.
• The transactions reported are typical for institutional investors managing their portfolios.

Related Party Transactions

• The transactions were executed by Sentinel Brokers Company, Inc., a majority-owned subsidiary of DSS, Inc.

Stakeholder Impact

• The share disposals by DSS, Inc. could negatively impact the share price of Impact Biomedical Inc., affecting current shareholders.
• The transactions may also signal a change in DSS, Inc.'s investment strategy regarding Impact Biomedical Inc.

Key Dates

Keywords

Form 4, Beneficial Ownership, Share Disposal, DSS, Inc., Impact Biomedical Inc., Sentinel Brokers Company, Inc., Stock Transaction